Skip to content

Evaluation the effect of propolis on rheumatoid arthritis

Determining the Effect of Propolis Supplementation on Inflammatory Factors and Oxidative Status in Women with Rheumatoid Arthritis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190407043194N2
Enrollment
48
Registered
2020-07-22
Start date
2021-08-06
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis rheumatoid. Rheumatoid arthritis, unspecified

Interventions

Intervention 1: Intervention group: Propolis supplement (Propolis supplement capsule containing 500 mg of propolis, Shahdineh Golha Pharmaceutical Company, 2 times a day, daily consumption for 3 month

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: People in the age range of 20-70 years Patients with moderate and severe disease activity score 28 Do not take antioxidant supplements for at least 1 month before starting the study The tendency to cooperate and sign informed written consent Diagnosis of the disease by a rheumatologist based on the criteria of the American College of Rheumatology

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Taking oral contraceptive pills History of chronic diseases such as diabetes mellitus, kidney failure, liver failure and cancer Having other autoimmune and inflammatory diseases Having Hormonal disorders, thyroid disorders Alcohol consumption and hookah smoke Smoking and being exposed to secondhand smoke

Design outcomes

Primary

MeasureTime frame
Total antioxidant capacity. Timepoint: Before and after of intervention. Method of measurement: Elisa kit.;Interleukin 17. Timepoint: Before and after of intervention. Method of measurement: Elisa kit.;Total oxidant status. Timepoint: Before and after of intervention. Method of measurement: Elisa kit.;Tumor necrosis factor alpha. Timepoint: Before and after of intervention. Method of measurement: Elisa kit.;Malondialdehyde. Timepoint: Before and after of intervention. Method of measurement: Elisa kit.;Glutathione peroxidase. Timepoint: Before and after of intervention. Method of measurement: Elisa kit.;Catalase. Timepoint: Before and after of intervention. Method of measurement: Elisa kit.;Superoxide dismutase. Timepoint: Before and after of intervention. Method of measurement: Elisa kit.;Triglyceride. Timepoint: Before and after of intervention. Method of measurement: Laboratory test.;Low density lipoprotein. Timepoint: Before and after of intervention. Method of measurement: Laboratory test.;High density lipoprotein. Timepoint: Before and after of intervention. Method of measurement: Laboratory test.;Blood pressure. Timepoint: Before and after of intervention. Method of measurement: Mercury barometer.;Dietary intake. Timepoint: Before and after of intervention. Method of measurement: Three days food record.;Physical activity. Timepoint: Before and after of intervention. Method of measurement: International Physical Activity Questionnaire.;Anthropometric measurements. Timepoint: Before and after of intervention. Method of measurement: Body mass index, waist circumference, Hip circumference.;High sensivity C-reactive protein. Timepoint: Before and after of intervention. Method of measurement: Elisa kit.;Monocyte Chemoattractant Protein-1. Timepoint: Before and after of intervention. Method of measurement: Elisa kit.;Nitric oxide. Timepoint: Before and after of intervention. Method of measurement: Elisa kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Khosravi

Mashhad University of Medical Sciences

Khosravim@mums.ac.ir+98 51 3800 2367

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026